For T-cell activation analysis, we employed markers such as HLA-DR, CD69, and CD30 (Fig 1P, T, and U–Y), the latter being particularly relevant because of its association with BIA-ALCL (Wolfram et al, 2012). The gene discussed is CD69; the disease is anaplastic large cell lymphoma.